NIH-funded research NIH-funded research

Advanced imaging technology for studying metabolic diseases

Official title: Zeiss LSM 900 with Airyscan 2

Funded at Columbia University Health Sciences · NIH-10868336 · Data updated 2026-11-12

This study is looking to improve a special type of imaging technology to help doctors see and understand the changes in cells and tissues caused by metabolic diseases like diabetes and atherosclerosis, so that patients can get better treatments based on these insights.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$505,388
NIH project number1S10OD034377-01A1
Project IDNIH-10868336 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals diagnosed with diabetes, obesity, atherosclerosis, or non-alcoholic fatty liver disease.

Less likely to help

Patients with metabolic disorders that are not related to the conditions being studied may not receive direct benefits from this research.

What this research studies

This research focuses on enhancing the capabilities of confocal microscopy to better visualize and quantify cellular and tissue changes associated with metabolic diseases such as diabetes and atherosclerosis. By acquiring a Zeiss LSM 900 with Airyscan 2, the project aims to improve the analysis of how these diseases progress and respond to treatments. Patients can benefit from the insights gained through this advanced imaging technology, which will help researchers understand the underlying mechanisms of their conditions more effectively.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic and treatment strategies for metabolic diseases.

How similar studies have gone: Previous research utilizing advanced imaging techniques has shown promising results in understanding metabolic diseases, indicating that this approach is likely to be beneficial.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Zeltser, Lori M — Columbia University Health Sciences
  • Study coordinator: Zeltser, Lori M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.